1. Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer
- Author
-
Roman A. Zubarev, Corina Mayrhofer, Yaroslav Lyutvinskiy, Kenneth Wester, Ulrika Segersten, Mårten Lindén, Per-Uno Malmström, Sara Bergström Lind, and Ulf Pettersson
- Subjects
Male ,Proteomics ,medicine.medical_specialty ,Urinary system ,Urology ,Dot blot ,Urine ,Biology ,Biochemistry ,Apolipoproteins E ,Western blot ,Biomarkers, Tumor ,medicine ,Humans ,Neoplasm Invasiveness ,Molecular Biology ,Aged ,Glycoproteins ,Aged, 80 and over ,Bladder cancer ,medicine.diagnostic_test ,Fibrinogen ,Middle Aged ,medicine.disease ,Blot ,ROC Curve ,Urinary Bladder Neoplasms ,alpha 1-Antitrypsin ,Immunology ,Biomarker (medicine) ,Female - Abstract
Nonmuscle invasive tumors of the bladder often recur and thereby bladder cancer patients need regular re-examinations which are invasive, unpleasant, and expensive. A noninvasive and less expensive method, e.g. a urine dipstick test, for monitoring recurrence would thus be advantageous. In this study, the complementary techniques mass spectrometry (MS) and Western blotting (WB)/dot blot (DB) were used to screen the urine samples from bladder cancer patients. High resolving MS was used to analyze and quantify the urinary proteome and 29 proteins had a significantly higher abundance (p
- Published
- 2011
- Full Text
- View/download PDF